The AI Company Transforming Medication Adherence and Weight Loss

Medication adherence remains one of the healthcare industry's greatest challenges, impacting clinical trials, commercial therapies, and patient outcomes across pharmaceutical and biotechnology companies. AiCure Corporation has spent years addressing this challenge with its pioneering medication adherence solutions, which leverage AI to remotely monitor medication adherence through a patient’s smartphone. AiCure’s new WeightVerify™ platform combines facial verification and OCR technology to deliver trusted remote weight monitoring for obesity, diabetes, cardiovascular disease, and other chronic conditions—helping both providers and patients improve engagement and outcomes.

Founded over 16 years ago, AiCure has raised over $70 million in venture capital with an initial NIH grant, and was recently acquired by Vive VC, a Silicon Valley venture capital firm. AICure has partnered with healthcare providers and more than 70 pharmaceutical and biotechnolo...